OAR 855-019-0460
Naloxone - Delivery of Care and Prescribing

(1)

A pharmacist, having determined that there is an identified medical need, can prescribe naloxone and the necessary medical supplies to administer naloxone for opiate overdose:
(a) When dispensing any opiate or opioid prescription in excess of 50 morphine milligram equivalents (MME);
(b) To an individual seeking naloxone;
(c) To an entity seeking naloxone.
(2) The pharmacist shall determine that the individual (or the individual on behalf of an entity) seeking naloxone demonstrates understanding of educational materials related to opioid overdose prevention, recognition, response, and the administration of naloxone.
(3) The pharmacist may prescribe naloxone in any FDA approved dosage form and the necessary medical supplies needed to administer naloxone.
(4) The pharmacist shall dispense the naloxone product in a properly labeled container.
(5) Naloxone may not be prescribed without offering to provide oral counseling to the authorized recipient, which may include dose, effectiveness, adverse effects, storage conditions, and safety.
(6) The pharmacist must document the encounter and the prescription, and maintain records for three years.
(7) Any person, having once lawfully obtained naloxone may possess, distribute or administer it for the purpose of reversing opiate overdose.

Source: Rule 855-019-0460 — Naloxone - Delivery of Care and Prescribing, https://secure.­sos.­state.­or.­us/oard/view.­action?ruleNumber=855-019-0460 (accessed May 26, 2025).

855–019–0100
Application 855–019–0110
Definitions 855–019–0120
Licensure 855–019–0122
Renewal of Licensure as a Pharmacist 855–019–0123
Liability Limitations for Volunteers 855–019–0125
Coaching from Board and Staff 855–019–0130
Licensure by Reciprocity 855–019–0140
NAPLEX Score Transfer 855–019–0150
Foreign Pharmacy Graduates 855–019–0160
Nuclear Pharmacists 855–019–0170
Reinstatement of License 855–019–0171
Reinstatement of a Revoked or Surrendered License 855–019–0200
General Responsibilities of a Pharmacist 855–019–0205
Duty to Report 855–019–0210
Duties of the Pharmacist Receiving a Prescription 855–019–0220
Drug Utilization Review (DUR) 855–019–0230
Counseling 855–019–0240
Consulting Pharmacist Practice 855–019–0250
Medication Therapy Management 855–019–0260
Collaborative Drug Therapy Management 855–019–0265
Administration of Drugs 855–019–0270
Immunization Qualifications 855–019–0280
Immunization Protocols, Policies and Procedures 855–019–0290
Immunization Record Keeping and Reporting 855–019–0300
Duties of a Pharmacist-in-Charge 855–019–0310
Grounds for Discipline 855–019–0400
Contraceptives - Purpose 855–019–0405
Contraceptives - Definitions 855–019–0410
Prescriptive Practice Consultation 855–019–0415
Contraceptive - Training Program 855–019–0425
Contraceptive - Procedural Mandates 855–019–0430
Contraceptive - Prohibited Practices 855–019–0435
Contraceptive - Records 855–019–0460
Naloxone - Delivery of Care and Prescribing 855–019–0470
Emergency Insulin

May 26, 2025

Rule 855-019-0460's source at or​.us